Michel Hamon

Q: What Schools Are Affiliated With Michel Hamon

Michel Hamon is affiliated with the following schools: Université Paris Cité, University of Bologna, Sorbonne University

Michel Hamon's AcademicInfluence.com Rankings

Michel Hamon

Computer Science

#3390

World Rank

#3556

Historical Rank

Data Mining

#36

World Rank

#36

Historical Rank

Algorithms

#95

World Rank

#95

Historical Rank

Machine Learning

#391

World Rank

#396

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Michel Hamon's Degrees

PhD Computer Science Université Paris Cité

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is Michel Hamon Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michel Hamon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT (1983) (758)
International Union of Pharmacology. XII. Classification of opioid receptors. (1996) (711)
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. (2001) (579)
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist (1995) (522)
Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats (1986) (513)
Somatodendritic localization of 5‐HT1A and preterminal axonal localization of 5‐HT1B serotonin receptors in adult rat brain (2000) (476)
[3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat Brain (1985) (440)
Neurotransmitter transporters in the central nervous system. (1999) (424)
Monoamine neurocircuitry in depression and strategies for new treatments (2013) (418)
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. (1985) (395)
International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. (1999) (383)
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system (1996) (375)
Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function (2003) (372)
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. (2000) (336)
Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. (1978) (335)
Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system (1997) (324)
Corticosteroid–serotonin interactions in the neurobiological mechanisms of stress-related disorders (2008) (313)
Direct Immunohistochemical Evidence of the Existence of 5‐HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei (1990) (292)
Altered expression and functions of serotonin 5‐HT1A and 5‐HT1B receptors in knock‐out mice lacking the 5‐HT transporter (2000) (283)
Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain (1984) (268)
Excessive Activation of Serotonin (5-HT) 1B Receptors Disrupts the Formation of Sensory Maps in Monoamine Oxidase A and 5-HT Transporter Knock-Out Mice (2001) (261)
Epigenetic regulation of the BDNF gene: implications for psychiatric disorders (2012) (252)
Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression (2003) (247)
Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine (2000) (245)
Serotonin and tolerance to delay of reward in rats (1999) (236)
Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism (1995) (235)
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. (1999) (235)
Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (2003) (233)
Behavioural disturbances associated with hyperdopaminergia in dopamine‐transporter knockout mice (2000) (227)
Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies (1999) (222)
Localization of 5-HT6 receptors at the plasma membrane of neuronal cilia in the rat brain (2000) (220)
Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. (1988) (209)
Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension (2004) (208)
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. (2003) (202)
Antibodies and Antisense Oligonucleotide for Probing the Distribution and Putative Functions of Central 5-HT6Receptors (1999) (202)
Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior (2000) (200)
Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension (2006) (198)
Quantitative RT‐PCR distribution of serotonin 5‐HT6 receptor mRNA in the central nervous system of control or 5,7‐dihydroxytryptamine‐treated rats (1996) (197)
Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. (2006) (194)
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism (2011) (192)
Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine (1995) (189)
5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. (1989) (188)
Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin (2008) (186)
Autoradiography of serotonin receptor subtypes in the central nervous system (1991) (180)
The topographical distribution of serotoninergic terminals in the spinal cord of the cat: biochemical mapping by the combined use of microdissection and microassay procedures (1977) (179)
Key Role of 5-HT1B Receptors in the Regulation of Paradoxical Sleep as Evidenced in 5-HT1B Knock-Out Mice (1999) (174)
The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. (1995) (172)
Serotonin Transporter Inhibition Prevents and Reverses Monocrotaline-Induced Pulmonary Hypertension in Rats (2005) (170)
Quantitative autoradiographic mapping of 5‐HT3 receptors in the rat CNS using [125I]iodo‐zacopride and [3H]zacopride as radioligands (1992) (169)
Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. (1984) (168)
Ultrastructural localization of 5‐hydroxytryptamine1A receptors in the rat brain (1996) (165)
Regulation of serotonin synthesis. (1974) (164)
5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals (1993) (162)
VGLUT3 (Vesicular Glutamate Transporter Type 3) Contribution to the Regulation of Serotonergic Transmission and Anxiety (2010) (161)
5-HT1 receptors. (2004) (160)
Contribution of 5-HT2 Receptor Subtypes to Sleep–Wakefulness and Respiratory Control, and Functional Adaptations in Knock-Out Mice Lacking 5-HT2A Receptors (2005) (158)
Involvement of 5-HT1A Receptors in Homeostatic and Stress-Induced Adaptive Regulations of Paradoxical Sleep: Studies in 5-HT1A Knock-Out Mice (2002) (156)
The topographical distribution of serotoninergic terminals in the neostriatum of the rat and the caudate nucleus of the cat (1977) (153)
Therapeutic Efficacy in Experimental Polyarthritis of Viral-Driven Enkephalin Overproduction in Sensory Neurons (2001) (149)
Acute Treatment with the Antidepressant Fluoxetine Internalizes 5-HT1A Autoreceptors and Reduces the In Vivo Binding of the PET Radioligand [18F]MPPF in the Nucleus Raphe Dorsalis of Rat (2004) (149)
Agonist-Induced Internalization of Serotonin-1A Receptors in the Dorsal Raphe Nucleus (Autoreceptors) But Not Hippocampus (Heteroreceptors) (2001) (149)
Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development (1987) (146)
The Central 5‐HT1A Receptors: Pharmacological, Biochemical, Functional, and Regulatory Properties a (1990) (146)
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice (2007) (145)
Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain (1990) (144)
Regional Differences in the Coupling of 5-Hydroxytryptamine-1A Receptors to G Proteins in the Rat Brain (2006) (141)
The main features of central 5-HT1 receptors. (1990) (141)
Deficiency of the 5-Hydroxytryptamine Transporter Gene Leads to Cardiac Fibrosis and Valvulopathy in Mice (2005) (139)
Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? (1995) (138)
Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain? (1986) (137)
Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain (1990) (133)
Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats (1980) (132)
Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. (1990) (132)
Autoradiographic evidence of serotonin1 binding sites on primary afferent fibres in the dorsal horn of the rat spinal cord (1987) (132)
Tyrosine hydroxylase activation in depolarized dopaminergic terminals—involvement of Ca2+ -dependent phosphorylation (1983) (131)
Differential subcellular localization of the 5‐HT3‐As receptor subunit in the rat central nervous system (2002) (130)
5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice (2009) (130)
5-Hydroxytryptamine (5-HT)1A Autoreceptor Adaptive Changes in Substance P (Neurokinin 1) Receptor Knock-Out Mice Mimic Antidepressant-Induced Desensitization (2001) (127)
Decreased convulsant potency of picrotoxin and pentetrazol and enhanced [3H]flunitrazepam cortical binding following stressful manipulations in rats (1980) (125)
Central serotonin1A receptors: Respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain (1991) (125)
Multiple roles of serotonin in pain control mechanisms--implications of 5-HT₇ and other 5-HT receptor types. (2013) (124)
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response (2012) (123)
Chronic treatment with imipramine reverses immobility behaviour, hippocampal corticosteroid receptors and cortical 5-HT1A receptor mRNA in prenatally stressed rats (2004) (122)
Neurochemical and Behavioral Alterations in Glucocorticoid Receptor-Impaired Transgenic Mice after Chronic Mild Stress (2004) (122)
Glucocorticoid receptor-mediated inhibition by corticosterone of 5-ht1a autoreceptor functioning in the rat dorsal raphe nucleus (1995) (121)
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats (2005) (120)
European neuropsychopharmacology: The journal of the European College of Neuropsychopharmacology (2009) (120)
Mice Lacking Brain/Kidney Phosphate-Activated Glutaminase Have Impaired Glutamatergic Synaptic Transmission, Altered Breathing, Disorganized Goal-Directed Behavior and Die Shortly after Birth (2006) (119)
Early Life Blockade of 5-Hydroxytryptamine 1A Receptors Normalizes Sleep and Depression-Like Behavior in Adult Knock-Out Mice Lacking the Serotonin Transporter (2006) (118)
Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. (2006) (118)
Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. (2010) (118)
5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. (1999) (116)
Regional Distribution of Calcitonin Gene‐Related Peptide‐, Substance P‐, Cholecystokinin‐, Met5‐Enkephalin‐, and Dynorphin A (1–8)‐Like Materials in the Spinal Cord and Dorsal Root Ganglia of Adult Rats: Effects of Dorsal Rhizotomy and Neonatal Capsaicin (1990) (112)
Functional Consequences of 5-HT Transporter Gene Disruption on 5-HT1A Receptor-Mediated Regulation of Dorsal Raphe and Hippocampal Cell Activity (2001) (109)
Differential Implication of Proinflammatory Cytokine Interleukin-6 in the Development of Cephalic versus Extracephalic Neuropathic Pain in Rats (2008) (108)
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease (2010) (108)
Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension: Critical Role for Serotonin-Induced Smooth Muscle Hyperplasia (2006) (107)
Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide (1990) (106)
Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain. (1992) (106)
Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter (1999) (105)
Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism (1990) (105)
Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse. (1994) (104)
Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord. (1986) (99)
Localization of 5-HT3 receptors in the rat spinal cord: immunohistochemistry and in situ hybridization. (1995) (99)
Opposite Effects of δ and μ Opioid Receptor Agonists on the In Vitro Release of Substance P‐Like Material from the Rat Spinal Cord (1987) (99)
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder (2002) (99)
Serotonin-sensitive adenylate cyclase and [3]serotonin binding sites in the CNS of the rat—I: Kinetic parameters and pharmacological properties (1980) (97)
Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action (2009) (96)
K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: Anin vitro electrophysiological study (1991) (96)
Lentiviral-mediated Targeted NF-κB Blockade in Dorsal Spinal Cord Glia Attenuates Sciatic Nerve Injury-induced Neuropathic Pain in the Rat. (2007) (95)
The antimigraine 5‐HT1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain‐related behaviour in a rat model of trigeminal neuropathic pain (2002) (95)
Up‐regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B‐dependent mechanisms (2002) (95)
Attenuation of induced-anxiety in rats by chlordiazepoxide: Role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons (1982) (94)
Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. I. Development and distribution of serotonin and dopamine-sensitive adenylate cyclases in rat and guinea pig brain. (1978) (94)
Central 5-HT(1A) receptors: regional distribution and functional characteristics. (2000) (94)
5‐HT1A and 5‐HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5‐HT1B knock‐out mice (1999) (93)
In situ hybridization evidence for the synthesis of 5‐HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain (1995) (93)
Altered regulation of the 5‐HT system in the brain of MAO‐A knock‐out mice (2002) (92)
Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. (1999) (91)
Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon Immunocytochemical localization and relationships (1983) (90)
Biological rhythms and melatonin in mood disorders and their treatments. (2013) (90)
Increased rewarding properties of morphine in dopamine‐transporter knockout mice (2000) (88)
3,4-Methylenedioxymethamphetamine Self-Administration is Abolished in Serotonin Transporter Knockout Mice (2007) (88)
Impacts of Brain Serotonin Deficiency following Tph2 Inactivation on Development and Raphe Neuron Serotonergic Specification (2012) (88)
Effects of LSD on synthesis and release of 5-HT in rat brain slices. (1974) (88)
Acetaminophen distribution in the rat central nervous system. (2001) (87)
In vivo release of 5-HT in the lateral ventricle of the rat: effects of 5-hydroxytryptophan and tryptophan (1976) (86)
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies. (1999) (86)
Lack of CB1 receptor activity impairs serotonergic negative feedback (2009) (86)
Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain (1983) (86)
Sex hormone‐dependent desensitization of 5‐HT1A autoreceptors in knockout mice deficient in the 5‐HT transporter (2003) (85)
FEEDBACK REGULATION OF 5‐HT SYNTHESIS IN RAT STRIATAL SLICES (1973) (85)
The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure (2003) (84)
Basic and Regulatory Mechanisms of In Vitro Release of Met‐Enkephalin from the Dorsal Zone of the Rat Spinal Cord (1984) (84)
Trophic effects of neurotransmitters during brain maturation. (1992) (84)
Effect of nerve activity on the in vivo release of [3H]serotonin continuously formed from l-[3H]tryptophan in the caudate nucleus of the cat (1979) (84)
Hippocampal Neurogenesis, Depressive Disorders, and Antidepressant Therapy (2007) (83)
Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibres projecting in the rat cervical cord (1989) (82)
Antagonist properties of (−)‐pindolol and WAY 100635 at somatodendritic and postsynaptic 5‐HT1A receptors in the rat brain (1998) (82)
Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons. (2005) (82)
In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. (1985) (82)
Postnatal development and localization of 5-HT1A receptor mRNA in rat forebrain and cerebellum. (1994) (82)
Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain (2004) (81)
Serotonergic signaling: multiple effectors and pleiotropic effects (2012) (81)
Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins. (1990) (81)
PLASMA TRYPTOPHAN AND 5‐HT METABOLISM IN THE CNS OF THE NEWBORN RAT (1974) (81)
Effects of acetaminophen on monoaminergic systems in the rat central nervous system (2001) (81)
SEROTONIN1A RECEPTORS ARE EXPRESSED BY A SUBPOPULATION OF CHOLINERGIC NEURONS IN THE RAT MEDIAL SEPTUM AND DIAGONAL BAND OF BROCA—A DOUBLE IMMUNOCYTOCHEMICAL STUDY (1996) (80)
Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline (1987) (79)
Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension? (2002) (79)
Formal Demonstration of the Phosphorylation of Rat Brain Tryptophan Hydroxylase by Ca2+/Calmodulin‐Dependent Protein Kinase (1989) (79)
Enhanced Cortical Extracellular Levels of Cholecystokinin-Like Material in a Model of Anticipation of Social Defeat in the Rat (2001) (79)
Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus. (1970) (78)
Central and peripheral 5-HT3 receptors (1992) (78)
[3H]HARMALINE AS A SPECIFIC LIGAND OF MAO A—I. PROPERTIES OF THE ACTIVE SITE OF MAO A FROM RAT AND BOVINE BRAINS (1979) (78)
Effects of a Dopamine D3 Receptor Ligand, BP 897, on Acquisition and Expression of Food-, Morphine-, and Cocaine-induced Conditioned Place Preference, and Food-seeking Behavior in Rats (2003) (78)
Severe Serotonin Depletion after Conditional Deletion of the Vesicular Monoamine Transporter 2 Gene in Serotonin Neurons: Neural and Behavioral Consequences (2011) (77)
5-HT-HPA Interactions in Two Models of Transgenic Mice Relevant to Major Depression (2000) (77)
SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. (1993) (77)
Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain (1997) (76)
RNA splicing and editing modulation of 5-HT2C receptor function: relevance to anxiety and aggression in VGV mice (2013) (76)
Baroreceptor reflex inhibition induced by the stimulation of serotonin3 receptors in the nucleus tractus solitarius of the rat (1992) (76)
Activation of tryptophan hydroxylase by adenosine triphosphate, magnesium, and calcium. (1978) (75)
Presynaptic Dopamine Autoreceptors Control Tyrosine Hydroxylase Activation in Depolarized Striatal Dopaminergic Terminals (1986) (73)
Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. (1986) (73)
The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia (2008) (73)
Noxious mechanical stimuli increase the release of Met-enkephalin-like material heterosegmentally in the rat spinal cord (1987) (72)
Pharmacological and Physicochemical Properties of Pre‐Versus Postsynaptic 5‐Hydroxytryptamine1A Receptor Binding Sites in the Rat Brain: A Quantitative Autoradiographic Study (1992) (72)
Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells. (1990) (71)
The respective roles of tryptophan uptake and tryptophan hydroxylase in the regulation of serotonin synthesis in the central nervous system. (1981) (71)
Serotonin 5-HT2A receptor involvement and Fos expression at the spinal level in vincristine-induced neuropathy in the rat (2008) (71)
Anpirtoline, a novel, highly potent 5‐HT1B receptor agonist with antinociceptive/antidepressant‐like actions in rodents (1992) (70)
Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains (1982) (69)
In vivo release of met-enkephalin in the cat brain (1981) (69)
Serotonin initiates and autoamplifies its own synthesis during mouse central nervous system development. (1986) (69)
Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. (2008) (69)
Association of 5-HT2A receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk (2002) (67)
Localization of met-enkephalin-like immunoreactivity within pain-related nuclei of cervical spinal cord, brainstem and midbrain in the cat (1983) (67)
Differential effects of stress on presynaptic and postsynaptic 5-hydroxytryptamine-1A receptors in the rat brain: an in vitro electrophysiological study (1999) (67)
Electrical stimulation of the nucleus raphe magnus in the rat. Effects on 5-HT metabolism in the spinal cord (1980) (67)
Spontaneous and evoked release of methionine-enkephalin-like material from the rat spinal cord in vivo (1985) (66)
Herpes Simplex Virus 1‐Mediated Transfer of Preproenkephalin A in Rat Dorsal Root Ganglia (1998) (66)
Developmental Changes in the Differential Expression of Two Serotonin 5‐HT3 Receptor Splice Variants in the Rat (1995) (66)
Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. (2007) (66)
Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525. (1993) (65)
Targeting of the 5-HT1A Serotonin Receptor to Neuronal Dendrites Is Mediated by Yif1B (2008) (65)
Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. (1996) (65)
THE ROLE OF INTRANEURONAL 5‐HT AND OF TRYPTOPHAN HYDROXYLASE ACTIVATION IN THE CONTROL OF 5‐HT SYNTHESIS IN RAT BRAIN SLICES INCUBATED IN K+‐ENRICHED MEDIUM (1979) (65)
Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness. (1979) (65)
Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo (1993) (65)
Alcohol intake after serotonin transporter inactivation in mice. (2003) (64)
TrkB inhibition as a therapeutic target for CNS-related disorders (2012) (64)
Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro. (1996) (63)
Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. II. Comparison with dopamine- and isoproterenol-sensitive adenylate cyclases in rat brain. (1978) (63)
125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies. (1988) (62)
Stress‐induced alterations of somatodendritic 5‐HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus — in vitro electrophysiological evidence (1997) (62)
Neuropharmacology of anxiety: perspectives and prospects. (1994) (62)
Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour. (2013) (62)
Vasoactive Intestinal Polypeptide Microinjections into the Oral Pontine Tegmentum Enhance Rapid Eye Movement Sleep in the Rat (1997) (62)
A Haplotype of the Norepinephrine Transporter (Net) Gene Slc6a2 is Associated with Clinical Response to Atomoxetine in Attention-Deficit Hyperactivity Disorder (ADHD) (2009) (61)
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives. (1998) (61)
Increased levels of met-enkephalin-like material in the CSF of anaesthetized cats after tooth pulp stimulation (1982) (61)
Novel, potent, and selective 5-HT3 receptor antagonists based on the arylpiperazine skeleton: synthesis, structure, biological activity, and comparative molecular field analysis studies. (1995) (61)
Characteristics of Tyrosine Hydroxylase Activation by K+‐Induced Depolarization and/or Forskolin in Rat Striatal Slices (1985) (61)
Effects of melatonin and agomelatine in anxiety-related procedures in rats: Interaction with diazepam (2006) (60)
Role of nucleus tractus solitarius 5-HT3 receptors in the defense reaction-induced inhibition of the aortic baroreflex in rats. (2003) (60)
Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices (1993) (60)
Acupuncture-like stimulation induces a heterosegmental release of Met-enkephalin-like material in the rat spinal cord (1991) (60)
Effects of ipsapirone, a 5‐HT1A agonist, on sleep/wakefulness cycles: probable post‐synaptic action (1993) (60)
Chronic alcoholization alters the expression of 5-HT1A and 5-HT1B receptor subtypes in rat brain. (1995) (59)
Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. (2007) (58)
5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout Mice (2003) (58)
Biochemical and functional alterations of central GABA receptors during chronic estradiol treatment (1983) (57)
Release of endogenous serotonin from two identified serotonin‐containing neurones and the physiological role of serotonin re‐uptake (1978) (57)
Role of serotonin3 receptors in the nucleus tractus solitarii on the carotid chemoreflex. (1997) (56)
Differential effects of calcitonin gene-related peptide receptor blockade by olcegepant on mechanical allodynia induced by ligation of the infraorbital nerve vs the sciatic nerve in the rat (2012) (56)
Stimulation of 5-HT3 receptors in the NTS inhibits the cardiac Bezold-Jarisch reflex response. (1996) (55)
Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. (1997) (55)
Immunolabeling of Central Serotonin 5‐HT1Dβ Receptors in the Rat, Mouse, and Guinea Pig with a Specific Anti‐Peptide Antiserum (1995) (55)
Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation (1991) (54)
BDNF-Dependent Plasticity Induced by Peripheral Inflammation in the Primary Sensory and the Cingulate Cortex Triggers Cold Allodynia and Reveals a Major Role for Endogenous BDNF As a Tuner of the Affective Aspect of Pain (2014) (54)
Enkephalinergic and dynorphinergic neurons in the spinal cord and dorsal root ganglia of the polyarthritic rat — in vivo release and cDNA hybridization studies (1997) (54)
Role of spinal serotonin 5-HT2A receptor in 2′,3′-dideoxycytidine-induced neuropathic pain in the rat and the mouse (2008) (53)
Homeostatic Regulation of Serotonergic Function by the Serotonin Transporter As Revealed by Nonviral Gene Transfer (2000) (53)
Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides (1999) (53)
Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines. (1996) (53)
Autoradiographic mapping of serotonin 5-HT1A, 5-HT1D, 5-HT2A and 5-HT3 receptors in the aged human spinal cord (1996) (53)
The lesion of serotonergic neurons does not prevent antidepressant-induced reversal of escape failures produced by inescapable shocks in rats (1986) (53)
[3H]Metergoline: A New Ligand of Serotonin Receptors in the Rat Brain (1981) (52)
Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture. (1994) (52)
Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact? (1989) (52)
Adaption of the serotoninergic neuronal phenotype in the absence of 5‐HT autoreceptors or the 5‐HT transporter: involvement of BDNF and cAMP (2004) (52)
5‐HT2C receptor activation prevents stress‐induced enhancement of brain 5‐HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment (2010) (52)
Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--II. Respective regional and subcellular distributions and ontogenetic developments. (1980) (51)
Subcutaneous formalin induces a segmental release of Met-enkephalin-like material from the rat spinal cord (1990) (50)
Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines. (1997) (50)
Effects of genetic depletion of monoamines on somatosensory cortical development (2002) (50)
Hyperplasia of pulmonary artery smooth muscle cells is causally related to overexpression of the serotonin transporter in primary pulmonary hypertension. (2002) (49)
Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1a , 5-HT1b and 5-HT3 receptors in the rat spinal cord (2005) (48)
Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity* (2001) (48)
Is Dopamine‐Induced Inhibition of Adenylate Cyclase Involved in the Autoreceptor‐Mediated Negative Control of Tyrosine Hydroxylase in Striatal Dopaminergic Terminals? (1986) (48)
Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. (2008) (48)
Acute changes in central serotonin metabolism induced by the blockade or stimulation of serotoninergic receptors during ontogenesis in the rat. (1977) (47)
The involvement of nigral serotonin innervation in the control of punishment-induced behavioral inhibition in rats (1983) (47)
A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine (2019) (47)
Opioidergic control of the spinal release of neuropeptides. Possible significance for the analgesic effects of opioids (1994) (47)
Ca2+‐Guanine Nucleotide Interactions in Brain Membranes. I. Modulation of Central 5‐Hydroxytryptamine Receptors in the Rat (1982) (47)
Characteristics of tryptophan accumulation by glial cells (1974) (47)
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. (2002) (47)
Life-Long Hippocampal Neurogenesis: Environmental, Pharmacological and Neurochemical Modulations (2007) (47)
5-HT2A gene promoter polymorphism as a modifying rather than a vulnerability factor in anorexia nervosa (2002) (46)
Role of the C-terminal di-leucine motif of 5-HT1A and 5-HT1B serotonin receptors in plasma membrane targeting (2006) (46)
Dominant Role of the Cytosolic C-Terminal Domain of the Rat 5-HT1B Receptor in Axonal–Apical Targeting (2000) (46)
Neonatal capsaicin treatment abolishes the modulations by opioids of substance P release from rat spinal cord slices (1989) (46)
The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women (2004) (45)
Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. (2001) (45)
Ethanol-induced epigenetic regulations at the Bdnf gene in C57BL/6J mice (2014) (45)
Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes. (1999) (45)
The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord (1999) (45)
Characterization of an Atypical Member of the Na+/Cl−‐Dependent Transporter Family: Chromosomal Localization and Distribution in GABAergic and Glutamatergic Neurons in the Rat Brain (1994) (45)
Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats (2001) (45)
5‐HYDROXYTRYPTAMINE CATABOLISM IN THE RAT BRAIN DURING ONTOGENESIS (1977) (45)
Interactions between TrkB Signaling and Serotonin Excess in the Developing Murine Somatosensory Cortex: A Role in Tangential and Radial Organization of Thalamocortical Axons (2002) (44)
Blockade of β1- and desensitization of β2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis (2004) (44)
Chronic voluntary ethanol intake hypersensitizes 5‐HT1A autoreceptors in C57BL/6J mice (2008) (44)
Toxic cardiac effects of catecholamines: role of β-adrenoceptor downregulation (2002) (44)
Acetaminophen: a central analgesic drug that involves a spinal tropisetron-sensitive, non-5-HT(3) receptor-mediated effect. (2004) (44)
GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain (2012) (44)
Sleep deprivation reduces the citalopram –induced inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis of the rat (1996) (43)
Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain. (1989) (43)
Prenatal developmental expression of rat brain 5-HT1A receptor gene followed by PCR. (1993) (43)
Characteristics of [14C]Guanidinium Accumulation in NG 108‐15 Cell Exposed to Serotonin 5‐HT3 Receptor Ligands and Substance P (1993) (43)
Effects of Peripheral Axotomy on Cholecystokinin Neurotransmission in the Rat Spinal Cord (1999) (43)
New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors. (1993) (42)
The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman. (1987) (42)
Central Serotonin Receptors (1984) (42)
Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain (1994) (42)
Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats (2003) (42)
Segmental release of Met-enkephalin-like material from the spinal cord of rats, elicited by noxious thermal stimuli (1989) (42)
Endothelial expression of the 5-hydroxytryptamine1B antimigraine drug receptor in rat and human brain microvessels (1998) (42)
Long‐term enhancement of REM sleep by the pituitary adenylyl cyclase‐activating polypeptide (PACAP) in the pontine reticular formation of the rat (1999) (41)
RAT BRAIN STEM TRYPTOPHAN HYDROXYLASE: MECHANISM OF ACTIVATION BY CALCIUM (1977) (41)
Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep (1996) (40)
Different localizations of met-enkephalin-like immunoreactivity in rat forebrain and spinal cord using hydrogen peroxide and Triton X-100. Light microscopic study (1983) (40)
Homeostatic Regulation of Sleep in a Genetic Model of Depression in the Mouse: Effects of Muscarinic and 5-HT1A Receptor Activation (2006) (40)
In vivo tonic inhibition of spinal substance P (-like material) release by endogenous opioid(s) acting at δ receptors (1991) (40)
Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment (1988) (40)
Gene therapy of chronic pain. (2003) (40)
Aggression and the Three Opioid Families (Endorphins, Enkephalins, and Dynorphins) in Mice (2003) (39)
Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy (2009) (39)
Unexpected localization of the Na+/Cl–‐dependent‐like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system (1999) (39)
Increased in vivo release of calcitonin gene-related peptide-like material from the spinal cord in arthritic rats (1993) (39)
Role of peripheral versus spinal 5‐HT7 receptors in the modulation of pain undersensitizing conditions (2012) (39)
Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine1A receptor (1994) (38)
Negative symptoms of schizophrenia could explain discrepant data on the association between the 5-HT2A receptor gene and response to antipsychotics (2005) (38)
Controversies on the role of 5-HT2C receptors in the mechanisms of action of antidepressant drugs (2014) (38)
Spontaneous and evoked release of met-enkephalin-like material from the spinal cord of arthritic rats in vivo (1988) (38)
Adult neurogenesis in serotonin transporter deficient mice (2007) (37)
The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances (2012) (37)
Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson’s disease (2011) (37)
5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. (2003) (37)
Modifications in the cortical regional distribution of choline acetyltransferase, somatostatin and somatostatin binding sites in the normal rat and following lesion of the nucleus basalis (1986) (37)
PROPERTIES OF PARTIALLY PURIFIED PIG BRAIN STEM TRYPTOPHAN HYDROXYLASE (1975) (37)
Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects? (2006) (37)
Origin of the acetyl moiety of acetylcholine synthesized in rat striatal synaptosomes. (1977) (36)
Opioid Control of the In Vitro Release of Cholecystokinin‐Like Material from the Rat Substantia Nigra (1992) (36)
Heterogeneous distribution of the serotonin 5‐HT1A receptor mRNA in chemically identified neurons of the mouse rostral brainstem: Implications for the role of serotonin in the regulation of wakefulness and REM sleep (2010) (36)
Neuronal localization of 5-HT1A receptor mRNA and protein in rat embryonic brain stem cultures. (1994) (36)
Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat (1992) (35)
Multiple receptors for serotonin in the rat brain. (1980) (35)
Stress‐ and Yohimbine‐Induced Release of Cholecystokinin in the Frontal Cortex of the Freely Moving Rat: Prevention by Diazepam but Not Ondansetron (1996) (35)
Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. (1995) (35)
GABAB receptors in 5‐HT transporter‐ and 5‐HT1A receptor‐knock‐out mice: further evidence of a transduction pathway shared with 5‐HT1A receptors (2004) (35)
Spinal Cord Transection-Induced Allodynia in Rats – Behavioral, Physiopathological and Pharmacological Characterization (2014) (35)
In vivo and in vitro activation of soluble tryptophan hydroxylase from rat brainstem (1976) (34)
Reappraisal of the serotonin 5-HT1B receptor gene in alcoholism: of mice and men (2002) (34)
Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats (2006) (34)
Visualization and quantification of central 5-HT1A receptors with specific antibodies (1991) (34)
Expression and G-protein coupling of μ-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats (2003) (34)
Up‐ and down‐expression of the dopamine transporter by plasmid DNA transfer in the rat brain (1998) (33)
Psychomotor, subjective and neuroendocrine effects of acute tryptophan depletion in the healthy volunteer (1990) (33)
Expression of Preproenkephalin A Gene and Presence of Met‐Enkephalin in Dorsal Root Ganglia of the Adult Rat (1994) (33)
End product inhibition of serotonin synthesis in the rat striatum. (1972) (33)
Differential anti-neuropathic pain effects of tetrodotoxin in sciatic nerve- versus infraorbital nerve-ligated rats – Behavioral, pharmacological and immunohistochemical investigations (2010) (33)
In vivo modulations by GABA-related drugs of met-enkephalin release in basal ganglia of the cat brain (1982) (33)
Extracellular dopamine in the rat prefrontal cortex during reward-, punishment- and novelty-associated behaviour. Effects of diazepam (2001) (33)
Effects of 5-HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat (1994) (33)
Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice. (2008) (32)
Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice. (2012) (32)
Antidepressant treatment in helpless rats: effect on the electrophysiological activity of raphe dorsalis serotonergic neurons (1997) (32)
Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization. (2009) (32)
Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra. (1987) (32)
Cannabinoid–serotonin interactions in alcohol‐preferring vs. alcohol‐avoiding mice (2006) (32)
The deletion of the microtubule‐associated STOP protein affects the serotonergic mouse brain network (2010) (32)
Long lasting effects of intrauterine growth retardation on 5-HT metabolism in the brain of developing rats (1981) (32)
Male-specific association between the 5-HTTLPR S allele and suicide attempts in alcohol-dependent subjects. (2005) (31)
Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors (1999) (31)
Cardiac baroreflex facilitation evoked by hypothalamus and prefrontal cortex stimulation: role of the nucleus tractus solitarius 5-HT2A receptors. (2006) (31)
Microtubule‐associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission (2007) (31)
Dopamine increases the expression of tyrosine hydroxylase and aromatic amino acid decarboxylase in primary cultures of fetal neurons. (1991) (31)
Cyclotraxin-B, a new TrkB antagonist, and glial blockade by propentofylline, equally prevent and reverse cold allodynia induced by BDNF or partial infraorbital nerve constriction in mice. (2012) (30)
Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships. (2009) (30)
[3H]HARMALINE AS A SPECIFIC LIGAND OF MAO A–II. MEASUREMENT OF THE TURNOVER RATES OF MAO A DURING ONTOGENESIS IN THE RAT BRAIN (1979) (30)
In situ molecular sizes of the various types of 5-HT binding sites in the rat brain. (1986) (30)
Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter (2001) (30)
Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities. (2002) (30)
Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5‐HT1A autoreceptors in mice (2005) (30)
The effects of quipazine on 5-HT metabolism in the rat brain (1976) (30)
The GTP‐Insensitive Component of High‐Affinity [3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin Binding in the Rat Hippocampus Corresponds to an Oxidized State of the 5‐Hydroxytryptamine1A Receptor (1991) (29)
Activation of nucleus tractus solitarius 5‐HT2A but not other 5‐HT2 receptor subtypes inhibits the sympathetic activity in rats (2007) (29)
Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics (2008) (29)
Immunocytochemical localization of 5-HT1A receptors in the rat immature cerebellum. (1993) (29)
Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material (1994) (28)
Direct stimulatory effect of calcitonin on [3H]5-hydroxytryptamine release from the rat spinal cord. (1988) (28)
Searching for endogenous ligand(s) of central benzodiazepine receptors (1983) (28)
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors. (1999) (28)
Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies (2004) (28)
γ-Aminobutyric acid, through GABAA receptors, inhibits the potassium-stimulated release of calcitonin gene-related peptide-but not that of substance P-like material from rat spinal cord slices (1992) (28)
Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence. (1995) (28)
Alterations in central neurotransmitter receptor binding sites following estradiol implantation in female rats (1983) (28)
N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain. (2011) (28)
In vivo release of calcitonin gene-related peptide-like material from the cervicotrigeminal area in the rat. Effects of electrical and noxious stimulations of the muzzle (1992) (28)
Physicochemical Properties of Serotonin 5‐HT3 Binding Sites Solubilized from Membranes of NG 108‐15 Neuroblastoma‐Glioma Cells (1990) (28)
Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat (1994) (27)
Differential pharmacological alleviation of oxaliplatin-induced hyperalgesia/allodynia at cephalic versus extra-cephalic level in rodents (2014) (27)
A New Vesicular Scaffolding Complex Mediates the G-Protein-Coupled 5-HT1A Receptor Targeting to Neuronal Dendrites (2012) (27)
Differential effects of d-fenfluramine and p-chloroamphetamine on H75 12 -induced depletion of 5-hydroxytryptamine and dopamine in the rat brain (1991) (27)
Immunolabelling of the 5‐HT3B receptor subunit in the central and peripheral nervous systems in rodents (2007) (27)
Phospholipid-induced activation of tryptophan hydroxylase from the rat brainstem. (1978) (27)
Delayed behavioral response to antidepressant drugs following selective damage to the hippocampal noradrenergic innervation in rats (1987) (27)
Involvement of α1-adrenoceptors in conditioned place preference supported by nicotine in rats (2009) (27)
The two orphan Na+/Cl(-)-dependent transporters Rxt1 and V-7-3-2 have an overlapping expression pattern in the rat central nervous system. (1996) (27)
Native and Cloned 5-HT3A(S) Receptors Are Anchored to F-Actin in Clonal Cells and Neurons (2002) (27)
5-HT release from ependymal surface of the caudate nucleus in ‘ence´phale isole´‘ cats (1977) (27)
The Interactions of the 5-HT(3) receptor with arylpiperazine, tropane, and quinuclidine ligands. (2002) (27)
Dopamine and methionine-enkephalin in human brain (1982) (27)
CHARACTERIZATION OF THE Ca2+‐INDUCED PROTEOLYTIC ACTIVATION OF TRYPTOPHAN HYDROXYLASE FROM THE RAT BRAIN STEM (1979) (26)
Are 5-HT receptors involved in the sprouting of serotoninergic terminals following neonatal 5,7-dihydroxytryptamine treatment in the rat? (1981) (26)
Stimulating effect of short term ether anaesthesia on central 5-HT synthesis and utilization in the mouse brain. (1973) (26)
Distribution of Met-enkephalin immunoreactive fibres in the thalamus of the cat (1986) (26)
The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system. (1992) (26)
The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats (2001) (26)
Fluoxetine‐induced desensitization of somatodendritic 5‐HT1A autoreceptors is independent of glucocorticoid(s) (1997) (26)
Involvement of the dorsolateral funiculi in the spinal release of Met-enkephalin-like material triggered by heterosegmental noxious mechanical stimuli (1987) (26)
Characteristics of tryptophan binding in the serum of the newborn rat. (1977) (26)
Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord. (2002) (26)
Chromatographic Analyses of the Serotonin 5‐HT1A Receptor Solubilized from the Rat Hippocampus (1989) (25)
In vivo and in vitro release of central neurotransmitters in relation to pain and analgesia. (1988) (25)
KAPPA-/MU-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord (1992) (25)
Brain circuits mediating baroreflex bradycardia inhibition in rats: an anatomical and functional link between the cuneiform nucleus and the periaqueductal grey (2011) (25)
NEUROTRANSMITTER AND NEUROMODULATORY MECHANISMS INVOLVED IN ALCOHOL ABUSE AND ALCOHOLISM. (2004) (25)
GABA, acting at both GABAA and GABAB receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro (1992) (25)
Is substance P released from slices of the rat spinal cord inactivated by peptidase(s) distinct from both ‘enkephalinase’ and ‘angiotensin-converting enzyme’? (1991) (25)
Family-based association study of the 5-HT transporter gene and schizophrenia. (2005) (25)
Blockade of beta 1- and desensitization of beta 2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis. (2004) (25)
Altered Sleep Homeostasis after Restraint Stress in 5-HTT Knock-Out Male Mice: A Role for Hypocretins (2009) (25)
δ2‐opioid receptor mediation of morphine‐induced CCK release in the frontal cortex of the freely moving rat (1999) (25)
5-HT-mediated inhibition of cardiovagal baroreceptor reflex response during defense reaction in the rat. (2004) (25)
Opioid control of the release of Met-enkephalin-like material from the rat spinal cord (1991) (24)
Midbrain raphe lesion in the newborn rat: II. Biochemical alterations in serotoninergic innervation (1977) (24)
Effects of Chronic Antidepressants in an Operant Conflict Procedure of Anxiety in the Rat (1999) (24)
Spinal Mechanisms of Opioid Analgesia (1998) (24)
Quantification of 5-hydroxytryptamine1a receptors in the cerebellum of normal and X-irradiated rats during postnatal development (1992) (24)
Acute and chronic effects of citalopram on 5‐HT1A receptor—Labeling by [18F]MPPF and—Coupling to receptors‐G proteins (2008) (23)
Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. 1. On the sleepwaking cycles (1979) (23)
[3H]Alnespirone: a novel specific radioligand of 5-HT1A receptors in the rat brain. (1997) (23)
Neuronal Phenotype Dependency of Agonist-Induced Internalization of the 5-HT1A Serotonin Receptor (2014) (23)
Differentiation Alters the Expression of the Two Splice Variants of the Serotonin 5‐HT3 Receptor‐A mRNA in NG108‐15 Cells (1995) (23)
Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat (1999) (22)
Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats (2015) (22)
Regulatory properties of neuronal tryptophan hydroxylase. (1981) (22)
Family-based association studies between 5-HT5A receptor gene and schizophrenia. (2004) (22)
Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats (2016) (22)
Differential addressing of 5HT1A and 5HT1B receptors in transfected LLCPK1 epithelial cells: a model of receptor targeting in neurons (1996) (22)
Model of brain serotonin metabolism. II. Physiological interpretation. (1983) (22)
Identification of the 5‐HT1A Receptor Binding Subunit in Rat Brain Membranes Using the Photoaffinity Probe [3H]8‐Methoxy‐2‐[N‐n‐Propyl, N‐3‐(2‐Nitro‐4‐Azidophenyl)Aminopropyl]Aminotetralin (1987) (22)
Critical role of B3 serotonergic cells in baroreflex inhibition during the defense reaction triggered by dorsal periaqueductal gray stimulation (2008) (21)
Chronic alnespirone-induced desensitization of somatodendritic 5-HT1A autoreceptors in the rat dorsal raphe nucleus. (1999) (21)
Irreversible blockade of central 5-HT binding sites by 8-methoxy-2'-chloro-PAT. (1985) (21)
Biochemical mapping of cholecystokinin-, substance P-, [met]enkephalin-, [leu]enkephalin- and dynorphin a (1–8)-like immunoreactivities in the human cerebral cortex (1988) (21)
Pharmacological and Biochemical Characterization of Rat Hippocampal 5‐Hydroxytryptamine1A Receptors Solubilized by 3–[3–(Cholamidopropyl)dimethylammonio]‐1‐Propane Sulfonate (CHAPS) (1988) (20)
CGRP receptor blockade by MK‐8825 alleviates allodynia in infraorbital nerve‐ligated rats (2015) (20)
Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat (2004) (20)
[3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies. (1991) (20)
Serotonin transporter and receptors in various forms of human pulmonary hypertension. (2005) (20)
60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress (2015) (20)
Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells. (1991) (20)
Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat (1998) (20)
δ-Opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in rats (2000) (20)
Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat. (1994) (20)
Differential Membrane Targeting and Pharmacological Characterization of Chimeras of Rat Serotonin 5‐HT1A and 5‐HT1B Receptors Expressed in Epithelial LLC‐PK1 Cells (1998) (19)
Dorsal medullary 5‐HT3 receptors and sympathetic premotor neurones in the rat (1998) (19)
5-HT2A receptors are expressed by catecholaminergic neurons in the rat nucleus tractus solitarii (2002) (19)
Intrathecal porcine calcitonin enhances the release of [Met5]enkephalin-like material from the rat spinal cord. (1989) (19)
5-HT1A receptors direct the orientation of plasticity in layer 5 pyramidal neurons of the mouse prefrontal cortex (2013) (19)
Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats (2005) (19)
Assessment of 5-HT7 Receptor Agonists Selectivity Using Nociceptive and Thermoregulation Tests in Knockout versus Wild-Type Mice (2012) (19)
Serotonin-receptors coupled with an adenylate cyclase in the rat brain: non-identity with 3H-5-HT binding sites. (1981) (19)
Muscarinic and PACAP receptor interactions at pontine level in the rat: significance for REM sleep regulation (2000) (19)
Control of the release of newly synthetized 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices (2004) (19)
5-HT2C Receptor Desensitization Moderates Anxiety in 5-HTT Deficient Mice: From Behavioral to Cellular Evidence (2015) (18)
Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord. (1987) (18)
Dihydroergotamine and its metabolite, 8′‐hydroxy‐dihydroergo‐tamine, as 5‐HT1A receptor agonists in the rat brain (2003) (18)
Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats. (1988) (18)
Anxiolytic‐like actions of anpirtoline in a mouse light‐dark aversion paradigm (1992) (17)
Modifications of the high and low affinity pituitary domperidone-binding sites in chronic estrogenized rats. (1983) (17)
Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines. (1972) (17)
Long-term treatment with the antioxidant drug EGb 761 at senescence restored some neurobehavioral effects of chronic ultramild stress exposure seen in young mice (2004) (17)
Toxic cardiac effects of catecholamines: role of beta-adrenoceptor downregulation. (2002) (17)
Biochemical and electrophysiological properties of SR 57746A, a new, potent 5‐HT1A receptor agonist (1993) (17)
Glucocorticoid receptor-dependent desensitization of 5-HT1A autoreceptors by sleep deprivation: studies in GR-i transgenic mice. (2006) (17)
Effects of tapentadol on mechanical hypersensitivity in rats with ligatures of the infraorbital nerve versus the sciatic nerve (2013) (17)
Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--I. (1980) (17)
Brain neuropeptides in progressive supranuclear palsy (1987) (17)
Functional interaction between nucleus tractus solitarius NK1 and 5-HT3 receptors in the inhibition of baroreflex in rats. (2005) (17)
Medullary pathways of cardiovascular responses to 5-HT2 and 5-HT3 receptor stimulation in the rat nucleus tractus solitarius (1996) (17)
Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression (2011) (17)
Altered opioid‐mediated control of the spinal release of dynorphin and met‐enkephalin in polyarthritic rats (2000) (17)
Midbrain raphe lesion in the newborn rat. I. Neurophysiological aspects of sleep (1977) (17)
Stimulation of 5-HT2 receptors in the nucleus tractus solitarius enhances NMDA receptor-mediated reflex-evoked bradycardiac responses in the rat (2001) (16)
The determination of picogram levels of 5‐HT in biological fluids (1976) (16)
Noxious stimulation excites serotonergic neurons: A comparison between the lateral paragigantocellular reticular and the raphe magnus nuclei (2013) (16)
GABA(B) receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors. (2004) (16)
Role of active transport of tryptophan in the control of 5-hydroxytryptamine biosynthesis. (1974) (16)
Estimation of the rate of 5-HT synthesis in the mouse brain by varius methods (2004) (16)
5‐HT3 receptor antagonism by anpirtoline, a mixed 5‐HT1 receptor agonist/5‐HT3 receptor antagonist (1995) (16)
Evidence for adenosine- and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy (2007) (16)
(−)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain (1993) (16)
Immunolabeling of the Na+/C1− dependent “orphan” transporter Rxt1 in the rat central nervous system (1995) (16)
Subcutaneous formalin enhances outflow of met-enkephalin- and cholecystokinin-like materials in the rat nucleus accumbens (2001) (15)
Somato-dendritic distribution of 5-HT1A and 5-HT1B autoreceptors in the BDNF- and cAMP-differentiated RN46A serotoninergic raphe cell line (2006) (15)
Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment (1992) (15)
Regulation of 5-HT Synthesis in Central Serotoninergic Neurons (1973) (15)
[Screening and management of bipolar disorders: results]. (2010) (15)
Long lasting effects of intrauterine growth retardation on basal and 5-HT-stimulated Na+/K+-ATPase in the brain of developing rats (1985) (15)
[Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine]. (1995) (15)
Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site. (1987) (15)
Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT. (1986) (15)
Ca2+‐Guanine Nucleotide Interactions in Brain Membranes. II. Characteristics of [3H]Guanosine Triphosphate and [3H]β, γ‐Imidoguanosine 5′‐Triphosphate Binding and Catabolism in the Rat Hippocampus and Striatum (1982) (15)
Local and remote effects of intra-caudate administration of GABA-related drugs on met-enkephalin release in the basal ganglion (1985) (15)
Immunocytochemical Distribution of VIP and PACAP in the Rat Brain Stem (2006) (15)
Feedback inhibition of met‐enkephalin release from the rat spinal cord in vivo (1992) (14)
Synthesis and release of serotonin in the median eminence of the rat. (1970) (14)
IN VITRO Ca2+ DEPENDENT PROTEOLYSIS IN BRAIN TISSUES: A POSSIBLE SOURCE OF ERROR IN TRANSMITTER METABOLISM STUDIES (1974) (14)
Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats (1995) (14)
Distribution Pattern and Ultrastructural Localization of Rxt1, an Orphan Na+/Cl−-Dependent Transporter, in the Central Nervous System of Rats and Mice (1997) (14)
Axonal Targeting of the 5‐HT1B Serotonin Receptor Relies on Structure‐Specific Constitutive Activation (2011) (14)
Ontogenesis of tryptophan transport in the rat brain. (1979) (14)
In vitro and in vivo disposition of 3H-methiothepin in brain tissues (1979) (13)
Prevention of diazepam withdrawal syndrome by nifedipine—behavioural and neurochemical studies (2004) (13)
Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression (1996) (13)
Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues. (1993) (13)
Inhibition of cardiac baroreflex by noxious thermal stimuli: A key role for lateral paragigantocellular serotonergic cells (2009) (13)
Rapid up‐regulation of the neuronal serotoninergic phenotype by brain‐derived neurotrophic factor and cyclic adenosine monophosphate: Relations with raphe astrocytes (2005) (13)
Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer’s Disease (2020) (13)
Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain? (1998) (13)
Effects of the novel analgesic, cizolirtine, in a rat model of neuropathic pain (2003) (13)
Serotoninergic control of punished behavior: effects of intra-raphe microinjections of chlordiazepoxide, GABA and 5-HT on behavioral suppression in rats. (1981) (13)
Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors. (1993) (13)
Localization of 5-HT1A serotonin receptors in the cerebellum of young rats (1991) (13)
Presence of met-enkephalin in a somatostatin-synthesizing cell line derived from the fetal mouse hypothalamus (1982) (12)
Selective irreversible blockade of 5-hydroxytryptamine1A and 5-hydroxytryptamine1C receptor binding sites in the rat brain by 8-MeO-′2-chloro-pat: A quantitative autoradiographic study (1989) (12)
Synthesis of 5‐[125I]‐iodo‐zacopride, a new probe for 5‐HT3 receptor binding sites (1991) (12)
c‐Fos induction in the rostroventrolateral medulla by 5‐HT3 receptor activation in the nucleus tractus solitarius (1998) (12)
Pharmaco-fUS for Characterizing Drugs for Alzheimer’s Disease – The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine (2020) (12)
Mechanisms of action of antidepressant drugs. (1978) (12)
[Alcohol dependence and polymorphisms of serotonin-related genes]. (2004) (12)
Expression, purification, and characterization of rat aromatic L-amino acid decarboxylase in Escherichia coli. (1997) (12)
Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal and median raphe nuclei of three genetically modified mouse models relevant to depression and anxiety (2011) (12)
Met-enkephalin-like immunoreactivity in rat forebrain and spinal cord using hydrogen peroxide and Triton X-100. Ultrastructural study (1983) (12)
Glutamate and NO mediation of the pressor response to 5-HT3 receptor stimulation in the nucleus tractus solitarii (2002) (12)
Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at ∂ opioid receptors (1994) (12)
Distinct effects of diazepam and NK1 receptor antagonists in two conflict procedures in rats (2003) (11)
[Role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine. Current hypotheses]. (2000) (11)
Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation. (1991) (11)
Pharmacological Evidence for the Involvement of Calciuml Calmodulin in Serotonin 5‐HT3 Receptor‐Mediated Cation Permeability in NG 108‐15 Cells (1994) (11)
5-HT1A-iCre, a new transgenic mouse line for genetic analyses of the serotonergic pathway (2007) (11)
Immunocytochemical evidence of vesicular localization of the orphan transporter Rxt1 in the rat spinal cord (1999) (11)
Reciprocal modulations of central 5-HT receptors by GTP and cations. (1983) (11)
Opposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation. (1999) (11)
Serotonin3 receptor stimulation in the nucleus tractus solitarii activates non-catecholaminergic neurons in the rat ventrolateral medulla (2002) (11)
Differential gene expression in mutant mice overexpressing or deficient in the serotonin transporter: A focus on urocortin 1 (2011) (11)
Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation. (1989) (11)
Differential effects of free versus imposed motor activity on alcohol consumption in C57BL/6J versus DBA/2J mice. (2009) (11)
Juvenile ethanol exposure increases rewarding properties of cocaine and morphine in adult DBA/2J mice (2013) (11)
Genetic association between helpless trait and depression-related phenotypes: evidence from crossbreeding studies with H/Rouen and NH/Rouen mice. (2012) (11)
Regional differences in the transduction mechanisms of 5-hydroxytryptamine receptors in the mammalian brain (1990) (11)
A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain (2019) (11)
Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker (1978) (10)
Characterization and distribution of Hxt1, a Na+/Cl−‐dependent orphan transporter, in the human brain (1999) (10)
Simultaneous measurement of beta-endorphin, lipotrophins and met-enkephalin in phaeochromocytomas. (1982) (10)
Molecular pharmacology of niaprazine (1988) (10)
Angiotensin II‐Like Material Extracted from the Rat Brain Is Distinct from Authentic Angiotensin II (1988) (10)
Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization. (1996) (10)
Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation (1979) (10)
Contribution of 5-HT 2 receptor subtypes to sleep-wakefulness and respiratory control , and functional adaptations in knock-out mice lacking 5-HT 2 A receptors (2016) (10)
Family‐based association study of the serotonin‐6 receptor gene (C267T polymorphism) in schizophrenia (2004) (10)
Differentiation of pre- and postsynaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents (1986) (10)
[Mechanisms of action of antidepressants: new data from Escitalopram]. (2003) (10)
Differential innervation of superficial versus deep laminae of the dorsal horn by bulbo-spinal serotonergic pathways in the rat (2017) (9)
Early exposure to ethanol differentially affects ethanol preference at adult age in two inbred mouse strains (2012) (9)
Differential effects of the novel analgesic, S 12813-4, on the spinal release of substance P- and calcitonin gene-related peptide-like materials in the rat (1994) (9)
Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice. (2004) (9)
Lentiviral vector-driven inhibition of 5-HT synthesis in B3 bulbo-spinal serotonergic projections – Consequences on nociception, inflammatory and neuropathic pain in rats (2017) (9)
Bradycardic responses to microinjection of N-methyl-d-aspartate into the nucleus tractus solitarius are inhibited by local activation of 5-HT3 receptors (2000) (9)
к-Opioid receptor stimulation abolishes μ- but not δ-mediated inhibitory control of spinal Met-enkephalin release (1992) (9)
Immunolabelling of the rat intestinal tract with antibodies specific to the long form of the 5-hydroxytryptamine3 receptor (1998) (9)
[Interactions between central opioidergic and cholecystokininergic systems in rats: possible significance for the development of of opioid tolerance]. (1998) (8)
Altered neurotensin mrna expression in mice lacking the dopamine transporter (2004) (8)
Long lasting effects of intrauterine malnutrition on neurotransmitters metabolism in the brain of developing rats. (1981) (8)
Partial expression of monoaminergic (serotoninergic) properties by the multipotent hypothalamic cell line F7. An example of learning at the cellular level (1986) (8)
Assessment of 5-HT 7 Receptor Agonists Selectivity Using Nociceptive and Thermoregulation Tests in Knockout versusWild-TypeMice (2014) (8)
Model of brain serotonin metabolism. I. Structure determination-parameter estimation. (1983) (8)
Extracellular serotonin is enhanced in the striatum, but not in the dorsal hippocampus or prefrontal cortex, in rats subjected to an operant conflict procedure. (2001) (8)
Chapter 17 – RADIOACTIVE LIGAND BINDING STUDIES: IDENTIFICATION OF CENTRAL SEROTONIN RECEPTORS (1984) (8)
Effects of halothane and nitrous oxide anaesthesia on 5-HT turn-over in the rat brain (2004) (8)
Long-term local and distal increases in tryptophan hydroxylase activity following intracerebral kainic acid injections in the rat (1982) (8)
MEDULLARY PATHWAYS OF CARDIOVASCULAR RESPONSES TO 5‐HT2 AND 5‐HT3 RECEPTOR STIMULATION IN THE RAT NUCLEUS TRACTUS SOLITARIUS (1997) (8)
Altered nociception in mice with genetically induced hypoglutamatergic tone (2015) (8)
The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord (2002) (7)
Effect of genetic and pharmacological blockade of GABA receptors on the 5‐HT2C receptor function during stress (2014) (7)
Melatonin MT1/2 receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat (2004) (7)
Inhibition of the bradycardic component of the von Bezold–Jarisch reflex and carotid chemoreceptor reflex by periaqueductal gray stimulation: involvement of medullary receptors (2009) (7)
[New perspectives in the serotoninergic treatment for depression]. (1995) (7)
Biochemical models for cognition enhancers. (1990) (7)
Normal CSF levels of met-enkephalin-like material in a case of naloxone—Reversible congenital insensitivity to pain (1984) (7)
Electrophysiological effects of WAY 100635, a new 5-HT1A receptor antagonist, on dorsal raphe nucleus serotoninergic neurones and CA1 pyramidal cells in vitro. (1996) (7)
Characteristics of serotonin receptors in the rat brain. (1980) (7)
Somatostatin alterations and brain diseases. (1985) (6)
Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment. (2020) (6)
[125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system]. (1988) (6)
[Screening and management of bipolar disorders: methodology]. (2010) (6)
The “Orphan” Na+/Cl‐‐Dependent Transporter, Rxt1, Is Primarily Localized Within Nerve Endings of Cortical Origin in the Rat Striatum (1999) (6)
Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). (1991) (6)
5-Hydroxytryptamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (6)
Ethanol and opiate decrease the axonal transport of substance-P like immunoreactive material in rat vagus-nerves (1990) (6)
gamma-Aminobutyric acid, through GABAA receptors, inhibits the potassium-stimulated release of calcitonin gene-related peptide- but not that of substance P-like material from rat spinal cord slices. (1992) (5)
Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors (2005) (5)
[Possible functional significance of the simultaneous release of several putative neurotransmitters by the same neuron]. (1984) (5)
Effects of chronic diazepam treatment on pre- and postsynaptic 5-HT1A receptors in the rat brain. (1997) (5)
The GABAergic Gudden's dorsal tegmental nucleus: A new relay for serotonergic regulation of sleep-wake behavior in the mouse (2018) (5)
Ontogeny of Rxt1, a vesicular “orphan” Na+/Cl−-dependent transporter, in the rat (2000) (5)
[(125I)iodo-zacopride: new ligand for the study by autoradiography of central 5-HT3 receptors]. (1990) (5)
Chronic chlorimipramine does not reverse the reduction of cerebrospinal fluid Met-enkephalin-like immunoreactivity in chronic-pain patients. (1987) (5)
Somato-dendritic 5-HT1A Autoreceptors in the Dorsal Raphe Nucleus; Pharmacological and Functional Properties (1991) (5)
Limited inhibition of 5-HT1A receptor expression in the rat brain by antisense RNA and oligodesoxynucleotides (1999) (5)
Antinociceptive effect of cardiopulmonary chemoreceptor and baroreceptor reflex activation in the rat (2002) (5)
Possible involvement of K(ATP) channels in the control of 5-HT neurons (1993) (4)
[Formalized expert recommendations. Screening and management of bipolar disorders]. (2010) (4)
Monoamine Transporters: Focus on the Regulation of Serotonin Transporter by Cytokines (2009) (4)
107 Mice overexpressing the 5-hydroxytryptamine transporter in smooth muscle cells spontaneously develop pulmonary hypertension (2005) (4)
α2- and β2-Adrenoreceptor-Mediated Efficacy of the Atypical Antidepressant Agomelatine Combined With Gabapentin to Suppress Allodynia in Neuropathic Rats With Ligated Infraorbital or Sciatic Nerve (2018) (4)
Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. III. Histochemical fluorescence and radioautographic studies of the noradrenaline hyperinnervation in the pons (1980) (4)
The Role of 5-HT2C Receptors in the Antidepressant Response: A Critical Review (2010) (4)
Erratum: International Union of Pharmacology. XXI. Structure, Distribution, and Functions of Cholecystokinin Receptors (Pharmacological Reviews (1991) 51 (745-781)) (2000) (4)
[From inflammation to pain: experimental gene therapy]. (2004) (4)
Specific Antibodies as New Tools for Studies of Central 5-HT 1A Receptors (1991) (3)
Biochemical Aspects of the Maturation of Serotoninergic Neurons in the Rat Brain (1977) (3)
Increased calcitonin gene-related peptide- and cholecystokinin-like immunoreactivities in spinal motoneurones after dorsal rhizotomy (2005) (3)
In vitro release of met-enkephalin and 3H-serotonin from the dorsal part of the lumbar cord in rats (1981) (3)
Un agent multiple : la sérotonine (1996) (3)
Functional and Regulatory Properties of Presynaptic Autoreceptors of the 5-HT1A Subtype on Dorsal Raphe Neurons in Brain Stem Slices (1991) (3)
Modulation of human myometrial PGE2 receptor by GTP characterization of receptor subtype. (1993) (3)
[Neurobiology of depression: new data]. (2005) (3)
Recent developments on the search for the endogenous ligand(s) of central benzodiazepine receptors (1988) (3)
Purification and Cloning of Central Serotonin Receptors (1990) (3)
In vitro and in vivo activation of tryptophan hydroxylase in the rat brain (1981) (3)
How Can Stress Alter Emotional Balance Through Its Interaction with the Serotonergic System (2011) (3)
Differential Localization and Regulation of Central 5-HT(1A) and 5-HT(3) Receptors (1992) (3)
Chronic phenytoin treatment decreases GABAA but not beta-adrenoceptors in the cerebellum of young rats. (1989) (3)
[Neuropathic pain. Physiopathological mechanisms and therapeutic perspectives]. (2008) (3)
Partial characterization of angiotensin II-like material extracted from the rat brain. (1986) (2)
22 - Solubilization and Physicochemical Characterization of 5-HT3 Receptor-Binding Sites (1993) (2)
ELECTROPHYSIOLOGICAL EVIDENCE FOR THE AGONIST PROPERTIES OF THE NEW POTENTIAL ANXIOLYTIC DRUG E-4424 ON SOMATODENDRITIC 5-HT1A AUTORECEPTORS (1992) (2)
Freezing of Enkephalinergic Functions by Multiple Noxious Foci: A Source of Pain Sensitization? (2009) (2)
Modulations of Central Serotonergic Neurotransmission by Chronic Ipsapirone in the Rat (1991) (2)
Pre- and Postsynaptic Location of 5-HT3 Receptors in the Rat Spinal Cord (1991) (2)
253 ANTI‐HYPERALGESIC EFFECTS OF 5‐HT7 RECEPTOR ACTIVATION IN RATS SUFFERING FROM NEUROPATHIC PAIN: ROLE OF GABAA RECEPTORS (2009) (2)
Kinetic characteristics of newly synthesized 3H-5-HT in the brain of control and reserpinized mice (1981) (2)
New Pharmacological Tools for Studies of Central 5-HT1A Binding Sites (1989) (2)
P.1.b.016 Differential features of allodynia associated with cephalic versus extra-cephalic neuropathic pain in rats (2015) (2)
CHOLECYSTOKININ EXERTS A TONIC EXCITATORY INFLUENCE ON THE SPINAL RELEASE OF MET-ENKEPHALIN IN THE RAT. (1995) (2)
S.04.07 Behavioural and neurochemical consequences of 5-HT transporter deletion on 5-HT2C receptor functions in mice (2010) (2)
Adaptation of central 5-HT1A receptors after chronic antidepressant treatment in rats (1991) (2)
[Neuroleptics and serotonin]. (1993) (2)
Mechanism of tyrosine hydroxylase activation by dopamine autoreceptor blockade in depolarized dopaminergic terminals (1985) (2)
P.2.d.009 Agomelatine, a novel pharmacological approach to treating depression (2006) (2)
[Neurobiological mechanisms of dependence: implication of serotonin]. (2002) (2)
Recent Advances in the Pharmacology of Central Serotoninergic Neurones (1984) (2)
In VivoModels for Drug Discovery (2014) (2)
P.6.d.015 MDMA self-administration is abolished in serotonin transporter knockout mice (2006) (1)
P.1.148 The novel antidepressant agomelatine (S 20098) acts independently of 5-HT1A receptors in the rat (2003) (1)
P.2.b.006 Effects of agomelatine and fluoxetine on hippocampal cell survival, glucocorticoid receptors and BDNF expression in a model of depression (2008) (1)
Visualization and Quantification of 5-HT1A Receptors in the Rat Brain by Radioimmunohistochemistry (1991) (1)
Glutamate and NOmediation of the pressor response to 5-HT3 receptor stimulation in the nucleus tractus solitarii (2002) (1)
P.1.h.025 Pharmacodynamic analyses of the anti-hyperalgesic and anti-allodynic effects of agomelatine in neuropathic rats (2014) (1)
S.20.03 Neuropeptide-monoamine interactions in normal and stress-altered sleep (2006) (1)
[Dopamine and serotonin. Involvement in the central effects of psychotropic agents]. (1989) (1)
Acute and chronic antidepressants: Effects in conflict models of anxiety in rats (1997) (1)
[The spinal enkephalinergic and serotoninergic systems in the control of transmission of nociceptive messages]. (1985) (1)
Possible Role of Serotonin and Other Monoamines as Growth Factors during Brain Development1 (1981) (1)
p.1.i.009 Behavioural and neurochemical characterisation of central neuropathic pain after spinal cord transection in the rat (2010) (1)
The 3Ns of Preclinical Animal Models in Biomedical Research (2014) (1)
[Transitory acute psychosis with serotoninergic syndrome at the time of an intoxication by dosulepin associated with doxylamine and ethanol]. (2006) (1)
[Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats]. (1991) (1)
Dopaminergic Antagonists Enhance Tyrosine Hydroxylase Activation in Depolarised Striatal Slices (1986) (1)
Purification of pig brainstem tryptophan hydroxylase and some of its properties. (1974) (1)
The role of 5-HT2B receptors in development of valvulopathy, cardiomyopathy, and pulmonary hypertension in Fawn-Hooded rats (2015) (1)
Presynaptic Autoreceptors May Control the Release of Metenkephalin from the Rat Spinal Cord (1991) (1)
Implication of transgenic models for mental disorders: Study of the dopamine neurotransmission system (1998) (1)
P.6.b.013 Effects of early ethanol consumption on cocaine- and morphine-induced conditioned place preference and ERK activation in mice (2011) (1)
Effects of two 5-HT1A agonist with anxiolytic properties: S 14506 and S 20499, on sleep-wakefulness regulations in the rat (1993) (1)
International Symposium on Fetal and Neonatal Neurology (1992) (1)
Increased release of met-enkephalin-like material (MELM) in the CSF of anaesthesized cats after tooth pulp stimulation (1981) (1)
Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release. (1992) (1)
The Key Role of Medullary 5-HT3 Receptors in the Serotonin-Mediated Neural Control of Cardiovascular Function. (2005) (1)
S.11.02 Brain region-dependent internalisation of 5-HT1A receptors: molecular mechanisms and relevance for antidepressant therapy (2012) (1)
Progress in opioid research : proceedings of the 19th International Narcotics Research Conference, 3-8 July 1988, Albi, France (1989) (1)
Delta receptor-dependent inhibition by morphine of the release of met-enkephalin-like material (MELM) from the rat spinal cord in vivo (1994) (0)
P.1.g.017 BDNF-TrkB mediation of mechanical hyperalgesia in a rat model of chronic neuropathic pain (2013) (0)
S01-04 - 5-HT2C Receptor Activation Inhibits Stress-Induced Increase in 5-HT Transmission: Relevance to the Effects of Antidepressant Drugs (2010) (0)
Inhibition Of Gut- And Lung-Derived Serotonin Prevents And Reverses Pulmonary Hypertension In Mice (2012) (0)
Medullary opiate peptides in a case of congenital insensitivity to pain (1985) (0)
New Trends in the Pharmacology of Central Serotoninergic Receptors (1985) (0)
P.4.10 Effects of early exposure to ethanol and/or a cannabinoid receptor agonist on alcohol preference at adult age in mice (2009) (0)
Effects of electrical and noxious peripheral stimulations on the spinal release of CGRP in the rat (1993) (0)
S.07.06 Epigenetic modifications of the BDNF gene at hippocampal level induced by chronic ethanol intake in C57BL/6J mice (2013) (0)
P.1.021 Serotoninergic 5-HT1A receptor internalisation and trafficking in cell lines and neurons: a role in desensitisation? (2011) (0)
Opioid control of the spinal release of cholecystokinin (CCK) in morphine-tolerant and non-tolerant rats (1994) (0)
Release and uptake of 5-hydroxytryptamine (5-H-T) by a single 5-HT containing neurone [proceedings]. (1976) (0)
P.1.g.039 Connexin channel inhibitor promotes the anti-hyperalgesic effect of amitriptyline in sciatic nerve-ligated rats (2014) (0)
242 CGRP‐RECEPTOR BLOCKADE BY BIBN4096BS REDUCES ALLODYNIA, FOS EXPRESSION AND ATF3 UPREGULATION IN A RAT MODEL OF TRIGEMINAL NEUROPATHIC PAIN (2009) (0)
S.04.05 Effects of early exposure to ethanol and/or a cannabinoid receptor agonist on alcohol preference at adult age in mice (2009) (0)
Effect of melatonin on delay of reward in rats (2003) (0)
S.12.03 Antidepressant-induced functional adaptive changes in 5-HT2C receptors: are they underlying their anxiolytic effects? (2010) (0)
Alterations in the spinal release of opioid peptides in arthritic rats affect the activity of substance P- and CGRP-containing primary afferent fibers (PAF) (1994) (0)
POTASSIUM CHANNELS CONTROL THE ELECTRICAL ACTIVITY OF SEROTONINERGIC NEURONS IN THE DORSAL RAPHE NUCLEUS. (1992) (0)
S.04.02 Neurobiological and behavioral effects of chronic mild stress in glucocorticoid receptor-impaired transgenic mice (2004) (0)
Pharmacological and biochemical properties of central 5-HT3 and 5-HT4 receptors (1993) (0)
[Anatomy of the bulbospinal serotoninergic pathways in the cat. Their role in morphine and electrically induced analgesia]. (1978) (0)
An Obituary to Jacques Glowinski (1936-2020). (2021) (0)
CS05.03 - Mouse strain related effects of cannabinoid and serotonergic ligands on alcohol appetence (2008) (0)
P.3.006 Epigenetic modifications of bdnf gene at hippocampal level induced by chronic ethanol intake in C57BL/6J mice (2013) (0)
[Clinical and neuro-physiopathological effects of an olanzapine overdose]. (2010) (0)
P.2.11 Crossbreeding studies with helpless “HIRouen” and “NH/Rouen” indicate that some phenotypic differences between the lines are related to the helpless trait (2005) (0)
P.1.g.024 5-HT7 receptor-mediated alterations of hyperalgesia in neuropathic rats selectively depleted in spinal 5-HT by intra-bulbar injection of a recombinant lentiviral vector (2016) (0)
C.05.04 Targeting the melatonergic system: a new approach to treat depression (2007) (0)
S.24.04 5-HT receptor modulation of anxiety (2011) (0)
[Serotonin: a player in both depression and bone remodeling]. (2010) (0)
Immunohistochemical Visualization of 5-HT1AReceptors in the Rat Brain (1993) (0)
Disappearance of the inhibitory but not of the excitatory effects of opioids on spinal CCK-containing neurons in morphine-tolerant rats (1994) (0)
In vivo and in vitro release of endogenous met-enkephalin, substance P and cholecystokinin from rat brain and spinal cord. Effects of peptidase inhibitors (1987) (0)
A124 MDMA-INDUCED LONG-TERM 5-HT1A RECEPTOR MODIFICATION IN MICE RAPHE DORSAL NUCLEUS (2005) (0)
CortexPotentiation in the Anterior Cingulate Calcium-Stimulated Adenylyl Cyclases Required for (2012) (0)
Involvement of the ~~ fun~ii in the ~ reb)ase of Met-enkephatin-ii~ m~, t ry: by lletefee41~Remal noxious ~~ stim,Jli (1987) (0)
Nonviral Gene Transfer Allows Up‐ and Down‐Expression of the Brain Serotonin Transporter with Functional Consequences (2003) (0)
P.1.14 Neurobiological and behavioral effects of chronic mild stress in glucocorticoid receptor-impaired transgenic mice (2004) (0)
P.1.c.017 New pathway involved in the alteration of reflex bradycardia in response to stress: study in rats and mice (2010) (0)
P.2.23 MDMA self-administration is abolished in serotonin transporter knock-out mice (2007) (0)
P27 INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE INCENTIVE VALUE OF NICOTINE (2004) (0)
P.1.a.023 Reduced sensitivity to nociceptive stimuli in mutant mice with low glutamatergic tone in the central nervous system (2010) (0)
C.15.02 Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects? (2006) (0)
THE POTENTIAL ANXIOLYTIC DRUG S 20499 IS A HIGHLY POTENT AND SELECTIVE AGONIST AT 5‐HT1A RECEPTORS IN THE RAT BRAIN (1992) (0)
14. Neuropathic Pain (2014) (0)
Increase in met-enkephalin level and antinociceptive effects induced by kelatorphan in the rat spinal cord. (1986) (0)
P.1.g.054 Effect of genetic and pharmacological blockade of GABA receptors on a serotonergic regulation of stress (2014) (0)
P.1.234 Antidepressant profile of the melatonin agonist and 5-HT2C antagonist agomelatine (S 20098). Preclinical studies (2003) (0)
390 NARATRIPTAN DIFFERENTIALLY ALLEVIATES OXALIPLATIN‐INDUCED NEUROPATHIC PAIN IN CEPHALIC VERSUS EXTRACEPHALIC TERRITORIES IN MICE (2009) (0)
Experimental neuropsychopharmacology, yesterday, today and tomorrow. A conversation with Michel Hamon. (2020) (0)
About the so-called “specific” binding of [3H]8-OH-DPAT to glass fiber filter (1988) (0)
P2.209 Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease (2009) (0)
GABAergic control of central serotonergic neurotransmission – role of GABA B receptors and possible implication in the antidepressant action of ketamine (2012) (0)
[Local metabolism of catecholamines in various nuclei of the brain in rats]. (1969) (0)
Kappa1/mu interactions in the control of the in vivo release of neuropeptides from the rat spinal cord (1994) (0)
Group report 6 : biochemical models for cognition enhencers (1990) (0)
P35 EFFECTS OF MELATONIN MT1/2 RECEPTOR AGONISTS ON ANXIETY-RELATED BEHAVIOUR IN RATS: INTERACTION WITH DIAZEPAM (2004) (0)
P.1.c.007 Is neuropathic pain alleviation by antidepressants mediated through anti-neuroinflammatory properties? (2012) (0)
S.04.03 Control of the dendritic targeting of the 5-HT1A serotonin receptor as an alternative antidepressant therapy (2011) (0)
P.1.h.006 Anti-allodynic effects of agomelatine combined with gabapentin in neuropathic rats with infraorbital nerve constriction (2013) (0)
Neuromethods Vol. 4, Receptor Binding Edited by A. A. Boulton, G. B. Baker and P. D. Hrdina. 584 pages. Price: £71.50. Humana Press, Clifton, New Jersey, 1986 (1988) (0)
Serotonin 3 receptor agonists into the nts inhibits the bradycardic but produced no changes in the respiratory and sympathetic responses to chemoreflex activation (1996) (0)
P.1.04 Serotonin transporter dependent effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) on the serotoninergic system and hippocampal cell proliferation in mice (2007) (0)
Are cortical excitability disturbances able to regulate meningeal nociceptive inputs to the trigeminocervical complex? A role of cortical spreading depression in the endogenous modulation of migraine pain (2010) (0)
Differential effects of 5HT transporter inhibitors and 5HT receptor antagonists on monocrotaline induced pulmonary hypertension in rats (2004) (0)
5-HT1A autoreceptors are desensitized in mice lacking the NK1 substance P receptor. (2000) (0)
Proenkephalin A gene expression in dorsal root ganglia of the rat: Modification by a noxious stimulus (1994) (0)
[GABA receptors in the central nervous system. Biochemical and pharmacological aspects]. (1987) (0)
P.2.b.020 5-HT2C receptor activation inhibits stress-induced increase in 5-HT transmission: relevance of receptor desensitization to the anxiolytic effect chronic antidepressant drugs and mutation in mice (2009) (0)
P.1.h.030 5-HT1A autoreceptors regulation in naïve and antidepressant-treated mice lacking the 5-HT3 receptor (2014) (0)
メテルゴリン,中枢5‐HT受容器しゃ断薬,による脳の5‐HTターンオーバの逆説的減少 (1978) (0)
[Sleep in the rate following raphe lesion: pharmacology of the serotonin system]. (1980) (0)
Calcitonin gene-related peptide-like material (CGRP-LM) is released from the cervicotrigeminal area by electrical and noxious thermal stimulation in the rat (1992) (0)
[Introduction. Physiological and physiopathological roles of serotonin: recent data from KO mice]. (2004) (0)
P.1.016 Control of the dendritic targeting of the 5-HT1A serotonin receptor as an alternative antidepressant therapy (2011) (0)
COMMUNICATION The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord (2002) (0)
S 21552???1: a non sedative 5HT1A agonist with anxiolytic and antidepressant-like effects in animals (1995) (0)
[Sleep and wakefulness regulation: molecular players]. (2011) (0)
Molecular Structure of the Central 5-HT1A Receptor (1990) (0)
[How far has the search for endogenous ligands of benzodiazepine receptors progressed?]. (1983) (0)
Neuropeptides in the basal ganglia of patients with Parkinson's or Steele‐Richardson's disease (1989) (0)
P.5.d.007 Effects of 5-HT7 receptor ligands in rats suffering from chronic neuropathic pain (2010) (0)
[Implication of serotoninergic and peptidergic systems in the mechanisms of pain]. (1988) (0)
323 HYPOSENSITIVITY TO NOXIOUS STIMULI AND INCREASED RESPONSE TO MORPHINE IN GLUTAMINASE‐DEFICIENT MICE (2009) (0)
[The possible role of neurotransmitter receptors in the mechanisms of action of antidepressants (author's transl)]. (1981) (0)
Interaction of aotidepressant drugs with opiold systems (1990) (0)
Is 5-HT3 receptor blockade able to prevent dopaminergic activation by stress (1991) (0)
B104 Differential Involvement of the Endocannabinoid System in the Establishment and the Short- And Long-Term Expression of Nicotine-Induced Conditioned Place Preference in Rats: (2005) (0)
[Is it feasible to develop a 5-HT basis for the treatment of depression?]. (1995) (0)
S.2.04 Are antidepressants really endowed with anxiolytic properties in relevant animal models? (2009) (0)
S.27.02 Regulation of the raphe: adaptive and maladaptive responses to stress (2009) (0)
The control of CGRP-containing primary afferent fibers by mu opioids is altered in chronic suffering rats (1994) (0)
POLYARTHRITISM-INDUCED DIFFERENTIAL CHANGES IN ENKEPHALINERGIC AND DYNORPHINERGIC NEURONES IN THE SPINAL CORD / DORSAL ROOT GANGLIA OF ADULT RATS (1995) (0)
Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension Integrative (2006) (0)
Goes beyond the Synapse (2004) (0)
P.2.018 Are 5-HT3 receptors modulating antidepressant-induced 5-HT1A autoreceptor desensitization in mice? (2014) (0)
P.2.03 Lack of CB1 receptor alters serotonin system: an electrophysiological and in vivo microdialysis study (2008) (0)
S.04.02 5HT-transporter dependent effects of MDMA (“ecstasy”) on the 5HT-system and hippocampal cell proliferation in mice (2007) (0)
Neurotransmitter interaction and compartmentation Edited by H. F. Bradford. Published by Plenum Press, New York, 1982. Price $95. ISBN 0-306-41015-X (1983) (0)
P.2.b.017 Lack of CB1 receptor alters serotonin system: an electrophysiological and in vivo microdialysis study (2008) (0)
P.2.b.021 First characterisation of tryptophan hydroxylase-2 (Tph2) knockout mice (2009) (0)
P.1.g.056 Potent and sustained anti-hyperalgesic and anti-allodynic effects of chronic administration of agomelatine in neuropathic rats (2015) (0)
S.24.05 Effects of chronic alcohol consumption on 5-HT system in mice (2007) (0)
[Effects of intraventricular injection of 5,7-dihydroxytryptamine on monoamines and sleep in the kitten (author's transl)]. (1981) (0)
084 Deficiency in Tryptophan Hydroxylase 1 (TPH1) gene or C1473G Polymorphism of the TPH2 Gene Alter Development of Hypoxic Pulmonary Hypertension in Mice (2007) (0)
Melatonin MT1/2 receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat. (2004) (0)
319 EFFECTS OF AMITRIPTYLINE, GABAPENTIN OR THEIR COMBINATION ON PAIN‐RELATED BEHAVIOURS IN TWO RAT MODELS OF CEPHALIC AND EXTRA‐CEPHALIC NEUROPATHIC PAIN (2006) (0)
CHAPTER 17 – SEARCHING FOR ENDOGENOUS LIGAND(S) OF CENTRAL BENZODIAZEPINE RECEPTORS (1985) (0)
S.23.01 Cardiovascular reflexes: physiological and pathophysiological influences from the brain (2007) (0)
Increased calcitonin gene-related peptide-like immunoreactivity (CGRPLI) in spinal motoneurones after dorsal rhizotomy (1991) (0)
[Toxophilic effects of morphinomimetic substances. Dopamine/enkephalin interactions in the ventral tegmental area and in the nucleus accumbens]. (1989) (0)
Chloride Channels and their Modulation by Neurotransmitters and Drugs—Advances in Biochemical Psychopharmacology: Vol. 45. Edited by Giovanni Biggio and E. Costa ISBN 0-88167-449-4. Price $106.50. Raven Press, New York, 1988 (1989) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michel Hamon?

Michel Hamon is affiliated with the following schools:

Michel Hamon's Academic­Influence.com Rankings

Michel Hamon's Degrees

Similar Degrees You Can Earn

Why Is Michel Hamon Influential?

Michel Hamon's Published Works

Published Works

What Schools Are Affiliated With Michel Hamon?

Michel Hamon's AcademicInfluence.com Rankings